Vaxart VXRT
OTC VXRT
$0.48 -0.01 (-1.94%)
As of: Oct 21, 2026 · 12:16 PM EDT

Vaxart (VXRT) Restructuring Costs (2020)

Updated

Vaxart (VXRT) reported Restructuring Costs of $971,000 for Q4 2020.

Analysis

Vaxart (VXRT) Restructuring Costs (2020) Analysis & Trends

For FY2020, Vaxart posted Restructuring Costs of $122,000, down 97.5% from FY2019.

  • By year, Restructuring Costs came in at $4.92 million in FY2019 and $359,000 in FY2018.
  • Per Business Quant data, the three quarters before Q4 2020 came in at -$952,000 (Q3 2020), $39,000 (Q2 2020) and $64,000 (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Vaxart 115.76 Mn 51.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 971,000.00
Sep 30, 2020 -952,000.00
Jun 30, 2020 39,000.00
Mar 31, 2020 64,000.00
API Access

Vaxart Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=VXRT&period=max&api_key=YOUR_API_KEY